A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001).

Anshul AgarwalAakanksha KhandelwalKavita PalNaveen Kumar KhareVishal JadhavMurarilal GurjarSachin PunatarAnant GokarnAvinash BondaLingaraj NayakSadhana KannanVikram GotaNavin KhattryIndraneel Mittra

Published in: PloS one (2022)

The trial was registered under Clinical Trial Registry of India (no.CTRI/2018/02/011905).

Keyphrases

high dose
clinical trial
multiple myeloma
phase ii
phase iii
study protocol
low dose
stem cell transplantation
anti inflammatory
open label
double blind
randomized controlled trial